1. 144 Hyperglycaemia alters NOX4 nadph oxidase-mediated endothelial cell regulation in vitro. (June 2018) Authors: Gill, Eleanor K; Edgar, Kevin S; Wilson, Adam J; Patterson, Ellen; Grieve, David J Journal: Heart Issue: Volume 104(2018)Supplement 6 Page Start: A104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 7 NOX4 NADPH oxidase is a key regulator of endothelial cell function in experimental diabetes. (26th March 2018) Authors: Gill, Eleanor K; Edgar, Kevin S; Wilson, Adam J; Patterson, Ellen; Grieve, David J Journal: Heart Issue: Volume 104(2018)Supplement 4 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. New insights into cardiotoxicity caused by chemotherapeutic agents. (18th October 2017) Authors: Grieve, David J; Davidson, Sean M Journal: British journal of pharmacology Issue: Volume 174:Number 21(2017) Page Start: 3675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. NOX4 is a major regulator of cord blood-derived endothelial colony-forming cells which promotes post-ischaemic revascularization. Issue 2 (1st April 2019) Authors: O'Neill, Karla M; Campbell, David C; Edgar, Kevin S; Gill, Eleanor K; Moez, Arya; McLoughlin, Kiran J; O'Neill, Christina L; Dellett, Margaret; Hargey, Ciarán J; Abudalo, Rawan A; O'Hare, Michael; Doyle, Philip; Toh, Tinrui; Khoo, Joshua; Wong, June; McCrudden, Cian M; Meloni, Marco; Brunssen, Co... Journal: Cardiovascular research Issue: Volume 116:Issue 2(2020) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes. (27th May 2016) Authors: Cowan, Elaine; Burch, Kerry J; Green, Brian D; Grieve, David J Journal: British journal of pharmacology Issue: Volume 173:Number 14(2016:Jul.) Page Start: 2165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting. Issue 4 (27th September 2017) Authors: Wilson, Adam J; Gill, Eleanor K; Abudalo, Rawan A; Edgar, Kevin S; Watson, Chris J; Grieve, David J Journal: Heart Issue: Volume 104:Issue 4(2018) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Selective targeting of glucagon‐like peptide‐1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes. (1st December 2014) Authors: Tate, Mitchel; Chong, Aaron; Robinson, Emma; Green, Brian D; Grieve, David J Journal: British journal of pharmacology Issue: Volume 172:Number 3(2015:Feb.) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase‐induced cardiomyopathy: involvement of mitofusin‐2. (22nd April 2017) Authors: McLaughlin, Declan; Zhao, Youyou; O'Neill, Karla M; Edgar, Kevin S; Dunne, Philip D; Kearney, Anna M; Grieve, David J; McDermott, Barbara J Journal: British journal of pharmacology Issue: Volume 174:Number 21(2017) Page Start: 3677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗